日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant Cancers.

LIG1 是 BRCA1 突变癌症中的合成致死靶点

Martires Lauren Catherine M, Ahronian Leanne G, Pratt Charlotte B, Das Nikitha M, Zhang Xiaobin, Whittington Douglas A, Zhang Hongxiang, Shen Binzhang, Come Jon, McCarren Patrick, Liu Mu-Sen, Min Chengyin, Feng Tianshu, Jahic Haris, Ali Janid A, Aird Daniel R, Li Fang, Andersen Jannik N, Huang Alan, Mallender William D, Nicholson Hilary E

Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency.

TNG348 的特性:一种选择性变构 USP1 抑制剂,可与 PARP 抑制剂在同源重组缺陷肿瘤中发挥协同作用

Simoneau Antoine, Pratt Charlotte B, Wu Hsin-Jung, Rajeswaran Shreya S, Comer Charlotte Grace, Sudsakorn Sirimas, Zhang Wenhai, Liu Shangtao, Meier Samuel R, Choi Ashley H, Khendu Tenzing, Stowe Hannah, Shen Binzhang, Whittington Douglas A, Chen Yingnan, Yu Yi, Mallender William D, Feng Tianshu, Andersen Jannik N, Maxwell John P, Throner Scott